Epinastine belongs to the class of second-generation antihistamines and is also a mast cell stabilizer. It also shows anti-leukotriene, anti-PAF, and anti-bradykinin activities, which provide additional anti-allergic activities. Antihistamines and mast cell stabilizers have been used to manage various allergic conditions for many years.

Currently, epinastine is FDA approved to treat:

Allergic conjunctivitis - Allergic conjunctivitis is an umbrella term that includes

- Perennial allergic conjunctivitis (PAC)

- Seasonal allergic conjunctivitis (SAC)

- Vernal keratoconjunctivitis (VKC)

- Atopic keratoconjunctivitis (AKC)

Epinastine is used in many countries to treat the following conditions as well:

- Chronic urticaria

- Psoriasis vulgaris

- Allergic Rhinitis

- Atopic Dermatitis

The chemical structure of epinastine is a benzazepine, which is 6,11-dihydro-5H-dibenzo[b,e]azepine in which the azepine ring merges with the side of 4,5-dihydro-1H-imidazole-2-amine. It is a member of benzazepine and guanidines. It is solid at room temperature, and the melting point is 205Â to 208 degrees Celsius.